Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Psychiatric Services (Washington, D.C.)|October 15, 2003
History and measurement of continuity of care in mental health services and evidence of its role in outcomesCarol E Adair, Gerald M McDougall, Anora Beckie, et al.The Journal of Pain|April 24, 2023
"I don't have chronic back pain anymore": Patient Experiences in Pain Reprocessing Therapy for Chronic Back PainHallie Tankha, Mark A Lumley, Alan Gordon, et al.Mental Health and Physical Activity|November 30, 2011
EXERCISE PREFERENCES OF PATIENTS IN SUBSTANCE ABUSE TREATMENTAna M Abrantes, Cynthia L Battle, David R Strong, et al.Journal of Addiction Medicine|February 4, 2017
How Should Remote Clinical Monitoring Be Used to Treat Alcohol Use Disorders?: Initial Findings From an Expert Round Table DiscussionAlan Gordon, Adi Jaffe, A Thomas McLellan, et al.Transboundary and Emerging Diseases|September 24, 2020
Co-infection status of novel parvovirus's (PPV2 to 4) with porcine circovirus 2 in porcine respiratory disease complex and porcine circovirus-associated disease from 1997 to 2012Paula Lagan Tregaskis, Anthony Staines, Alan Gordon, et al.Journal of the National Cancer Institute|November 18, 2004
Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinomaPaul A Vasey, Gordon C Jayson, Alan Gordon, et al.Journal of Studies on Alcohol and Drugs|March 11, 2011
A randomized controlled trial of cognitive-behavioral treatment for depression versus relaxation training for alcohol-dependent individuals with elevated depressive symptomsRichard A Brown, Susan E Ramsey, Christopher W Kahler, et al.Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|September 30, 2004
Continuity of care in mental health services: toward clarifying the constructAnthony S Joyce, T Cameron Wild, Carol E Adair, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 25, 2009
The Immune adjuvant properties of front-line carboplatin-paclitaxel: a randomized phase 2 study of alternative schedules of intravenous oregovomab chemoimmunotherapy in advanced ovarian cancerPatricia Braly, Christopher F Nicodemus, Christina Chu, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 14, 2017
Selective BET Protein Inhibition with Apabetalone and Cardiovascular Events: A Pooled Analysis of Trials in Patients with Coronary Artery DiseaseStephen J Nicholls, Kausik K Ray, Jan O Johansson, et al.Pageof 4